Since 2004, Alosa Health, a non-profit organization, has been the recognized national leader in academic detailing, a proven method to change prescriber behavior. Meeting clinicians where they are, addressing their individual needs, and developing personal relationships creates a trusting environment to deliver effective education that changes clinician decision-making.
Federal and state agencies, health insurers and health systems partner with Alosa to help them improve management and prescribing around specific clinical topics, comply with HEDIS, CMS Star Rating Program or other quality improvement and assurance measures. They also turn to Alosa to develop new clinical topic materials or train their own medical educators.
Health policy decision-makers engage Alosa’s medication policy team to analyze healthcare data from sources such as pharmacy claims and state prescription drug programs (PDMPs). Our team has expertise in a range of policy research areas including evaluating innovative drug pricing models and recommending strategies for state payors.
Over 95% of clinicians who met with Alosa academic detailers across the state of Pennsylvania reported that the visit and accompanying materials impact their clinical decision-making.
For more than twenty years, Alosa has deployed specially trained pharmacists, nurse practitioners, physician assistants and physicians across thirty-three states to engage clinicians in interactive, evidence-based discussions about clinical care and prescribing choices. This approach allows us to deliver educational outreach that is customized to each clinician’s practice, knowledge, and schedule. Numerous clinical trials have shown that this prescriber-focused method is the most effective way to improve clinical decision-making.
Insurers, health systems and governmental agencies know well that their memos, reminders, faxed letters and chart alerts often go unread, rarely changing clinician decision-making. Formulary restrictions and co-pay adjustments can frustrate clinicians and patients alike. Our highly trained academic detailers can help solve this challenge.
"I trust Alosa's clinical educators to give me the latest evidence for treatment options in challenging clinical topics. I know I can always rely on Alosa to advise me on my best prescribing options."
Alosa Health’s trained academic detailers have conducted over 115,000 visits and reached more than 5,000 prescribers in 33 states across twenty-three clinical topics. Our proven educational approach continues to bridge the critical gap between the best available evidence and practice.
Too often, front-line clinicians are overwhelmed by competing demands, leaving insufficient time to stay current with the latest evidence on the comparative effectiveness of treatments they prescribe every day – including the non-pharmacological aspects of care. Our educational materials are unbiased, succinct, accessible and include a range of needed extra support – from advanced care planning documents in our cognitive impairment topic to quick reference cards highlighting first-line medications in our pain management materials. Special lay-language handouts for patients help enlist them in adopting preferred treatment regimens.
By connecting clinical evidence with practical application, we empower clinicians to make confident treatment decisions based on the most current research. We are proud to partner with clinicians, supporting their dedication to high-quality care and addressing burnout – not by adding to their workload, but by enhancing and uplifting their expertise.
"The academic detailing session on chronic pain was outstanding! The evidence-based insights and practical strategies were exactly what I needed to enhance my approach to patient care. It left me feeling more confident in managing complex cases and genuinely uplifted about my role as a physician. I’m excited to apply this knowledge and already see the positive impact!"
Health systems and state governments are under growing pressure to develop and evaluate programs to make medication use affordable, and to ensure access to key prescription drugs in the face of rising costs. Increasingly complex federal and state regulations shape access to medications and influence how much patients and payers spend on prescription drugs. Alosa clinician advisors with expertise in health policy research are national experts with years of experience working with state and federal legislators and regulators as well as with private-sector organizations to address questions of comparative effectiveness and cost. We can help develop, implement, and evaluate evidence-based solutions to improve the use and affordability of prescription medications at the system level.
Proudly unbiased: Alosa Health, its staff, and our clinical and health policy advisors do not accept consulting fees from the pharmaceutical industry. This policy is fundamental to Alosa Health’s mission of providing unbiased, evidence-based clinical education and outreach to clinicians and policymakers. By maintaining this independence, Alosa ensures we deliver impartial and trustworthy information to clinicians and health policymakers.
— Tom Snedden
Director, Pharmaceutical Assistance Contract for the Elderly (PACE), Pennsylvania Department of Aging
© 2025 Alosa Health. All rights reserved.